Novartis Venture Fund
The Novartis Venture Fund is dedicated to fostering innovation in the life sciences sector, with a mission to drive significant patient benefits and generate superior returns. The fund invests in biotechnology and biopharmaceutical companies at various stages of growth, managing over USD 750 million in committed capital across more than 40 portfolio companies in North America and Europe. The fund focuses on developing novel therapeutics and platforms to address unmet patient needs globally.
Novartis Venture Fund
Portfolio
Developing medicines for hard-to-treat diseases using next-generation targeted protein degradation approaches.
#Platform
Developing large-molecule therapeutics to treat arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D).
#Cardiovascular